Safety and efficacy outcomes of a novel hysterosacropexy: A fertility sparing, uterine preserving pelvic organ prolapse surgery
Elmantwe,, A., Elnory, M. (2018). Safety and efficacy outcomes of a novel hysterosacropexy: A fertility sparing, uterine preserving pelvic organ prolapse surgery. EKB Journal Management System, 8(3), 199-206. doi: 10.21608/ebwhj.2018.15470
Ashraf Nassif Elmantwe,; Mohamed Anwar Elnory. "Safety and efficacy outcomes of a novel hysterosacropexy: A fertility sparing, uterine preserving pelvic organ prolapse surgery". EKB Journal Management System, 8, 3, 2018, 199-206. doi: 10.21608/ebwhj.2018.15470
Elmantwe,, A., Elnory, M. (2018). 'Safety and efficacy outcomes of a novel hysterosacropexy: A fertility sparing, uterine preserving pelvic organ prolapse surgery', EKB Journal Management System, 8(3), pp. 199-206. doi: 10.21608/ebwhj.2018.15470
Elmantwe,, A., Elnory, M. Safety and efficacy outcomes of a novel hysterosacropexy: A fertility sparing, uterine preserving pelvic organ prolapse surgery. EKB Journal Management System, 2018; 8(3): 199-206. doi: 10.21608/ebwhj.2018.15470

Safety and efficacy outcomes of a novel hysterosacropexy: A fertility sparing, uterine preserving pelvic organ prolapse surgery

Evidence Based Women's Health Journal
Article 2, Volume 8, Issue 3, August 2018, Page 199-206  XML PDF (736.87 K)
Document Type: Original Article
DOI: 10.21608/ebwhj.2018.15470
View on SCiNiTO View on SCiNiTO
Authors
Ashraf Nassif Elmantwe, email 1; Mohamed Anwar Elnory2
1Department of Obstetrics and Gynecology, Benha University, Benha, Egypt,
2Department of Obstetrics and Gynecology, Faculty of Medicine, Benha University, Egypt
Abstract
Objective: To access the safety and efficacy outcomes of a new abdominal Hysterosacopexy with CESA (Cervico-sacropexy) DynaMesh kit in treating advanced uterovaginal prolapse in young women aiming in uterine preservation pelvic organ prolapse (POP) surgery.
Patients and Methods: Prospective nonrandomized controlled clinical trial enrolled consecutive women attending the gynecology and obstetrics Department, Benha University Hospital for treatment of POP of stage II or greater on POP quantification (POPQ) system on the apical domain. Participants underwent abdominal hysterosacropexy utilizing CESA mesh kit of DynaMesh. POPQ staging, women symptoms, and quality of life were evaluated before and after surgery, as well as surgery-related morbidity.
Results: The current study enrolled 20 women, all women were followed up for a period of 18 months postoperatively. Significant post-surgical anatomical success was recorded across both POPQ anterior (point Aa, Ba) (P ≤ 0.0001, P ≤ 0.0001), apical (point c, d) (P ≤ 0.0001, P≤ 0.0001) and Posterior (point Ap, Bp) (P ≤ 0.0001, P≤ 0.0001) domains. Significant post-surgical functional improvements were recorded across prolapse symptoms, (bulge symptoms, overactive bladder, stress urinary incontinence, bowel dysfunction, sexual dysfunction) (P ≤ 0.0001, P = 0.0064, P = 0.03, P = 0.008, P ≤ 0.0001) respectively. ICIQ-VS (VS – SS – QOL) score (P≤ 0.0001, P ≤ 0.0001, P ≤ 0.0001). ICIQ – UI – SF score (P ≤ 0.0001). No major complications occurred. No mesh erosions were reported.
Conclusion: Abdominal hysterosacropexy with CESA DynaMesh kit seems to be a safe and effective option for women with advanced uterovaginal prolapse aiming for uterine preserving POP surgery.
Keywords
Cervico-sacropexy(CESA); CESA DynaMesh; hysterosacropexy; polyvinylidene fluoride (PVDF); Spinal anesthesia
Statistics
Article View: 278
PDF Download: 517